Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 458 JPY 0.34% Market Closed
Market Cap: 83.8B JPY
Have any thoughts about
Kyorin Holdings Inc?
Write Note

Gross Margin
Kyorin Holdings Inc

42.9%
Current
45%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
42.9%
=
Gross Profit
51.3B
/
Revenue
119.7B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
JP
Kyorin Holdings Inc
TSE:4569
83.8B JPY
43%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
US
Eli Lilly and Co
NYSE:LLY
755.8B USD
81%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK
85%
US
Johnson & Johnson
NYSE:JNJ
351.1B USD
69%
US
Merck & Co Inc
NYSE:MRK
251.8B USD
77%
CH
Roche Holding AG
SIX:ROG
200.1B CHF
73%
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP
82%
CH
Novartis AG
SIX:NOVN
171.5B CHF
75%
US
Pfizer Inc
NYSE:PFE
151.5B USD
71%
Country JP
Market Cap 83.8B JPY
Gross Margin
43%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 755.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.7T DKK
Gross Margin
85%
Country US
Market Cap 351.1B USD
Gross Margin
69%
Country US
Market Cap 251.8B USD
Gross Margin
77%
Country CH
Market Cap 200.1B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 171.5B CHF
Gross Margin
75%
Country US
Market Cap 151.5B USD
Gross Margin
71%
No Stocks Found

Kyorin Holdings Inc
Glance View

Market Cap
83.8B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Intrinsic Value
2 159.31 JPY
Undervaluation 32%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
42.9%
=
Gross Profit
51.3B
/
Revenue
119.7B
What is the Gross Margin of Kyorin Holdings Inc?

Based on Kyorin Holdings Inc's most recent financial statements, the company has Gross Margin of 42.9%.